Valneva SE (VALN)

[p0]

Around 65% of the EU population has already had
two vaccine doses,3 while just 4% of those in low
income countries have received at least one dose.4
This has raised questions over why Valneva focus
for approval and rollout is on the EU.

Penny Ward, visiting professor in pharmaceutical
medicine at King’s College London, said that the UK’s
order cancellation could allow Valneva “to provide
an immediate supply of the vaccine for other
countries struggling with the freezer shipping
requirements of other, more expensive, vaccines.
Good news for Covax [the international covid vaccine
alliance] and countries still awaiting supplies.”

Announcing the deal, the EC hinted that its interest
in the vaccine could relate to new variants. EC
president Ursula von der Leyen said, “The contract
allows for the vaccine to be adapted to new variants.
Our broad portfolio will help us to fight covid-19 and
its variants in Europe and beyond. The pandemic is
not over. Everyone who can, should get vaccinated.”